SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

GlaxoSmithKline Pharmaceuticals reports marginal rise in Q4 net profit

19 Feb 2013 Evaluate

GlaxoSmithKline Pharmaceuticals has reported results for fourth quarter ended December 31, 2012.

The company has reported 1.29% rise in its net profit at Rs 138.51 crore for the quarter as compared to Rs 136.74 crore for the same quarter in the previous year. Total income of the company has increased by 13.74% at Rs 704.34 crore for quarter under review as compared to Rs 619.25 crore for the quarter ended December 31, 2011.

For the entire 2012 fiscal, the company’s net profit surged 34.06% to Rs 577.26 crore from Rs 430.60 crore in the previous fiscal. The total income from operations went up by 11.37% to Rs 2823.78 crore from Rs 2535.50 crore in last year.

For the entire fiscal, the company’s consolidated net profit rose 31.10% to Rs 561.88 crore from Rs 428.58 crore in the previous fiscal. The total consolidated income of the company went up by 10.36% to Rs 2824.85 crore from Rs 2559.67 crore in last year.

Glaxosmithkline Phar Share Price

2451.80 32.70 (1.35%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×